SABCS: Anastrozole Tied to Lasting Reduction in Breast Cancer Risk

TUESDAY, Dec. 17, 2019 -- Anastrozole is associated with a long-term reduction in breast cancer risk, even after treatment, according to a study published online Dec. 12 in The Lancet to coincide with the annual San Antonio Breast Cancer Symposium,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news